ORA OHAFO Implementation of Incoming Firm Correspondence SOP

FDA has provided notice to NTEU of ORA’s plan to implement an Incoming Firm Correspondence SOP.

professional letter signature line and pen
Photo by Pixabay on Pexels.com
In accordance with Article 3, Section 2B, of the parties’ Consolidated Collective Bargaining Agreement, the Food and Drug Administration provided notice to NTEU of the Office of Regulatory Affairs (ORA), Office of Human and Animal Foods Operations’ (OHAFO) plan to implement an Incoming Firm Correspondence Standard Operating Procedures (SOP). The agency states that the purpose of this SOP is to establish a standardized process for proper receipt and distribution of all types of incoming firm correspondence for OHAFO. Further, the proposed SOP provides clear direction and formalizes the process for actions taken on incoming firm correspondence, ensuring that the process is harmonized across all OHAFO. NTEU has requested a briefing on this SOP.  If you have any questions or comments regarding the proposed SOP, please share them with your chapter president expeditiously.

Author: chapterpresident

I have worked in the FDA since 1990 in a variety of positions. I currently serve as chapter president of NTEU Chapter 254, representing FDA employees in Arkansas, Colorado, Iowa, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah.